Insmed (INSM) Return on Invested Capital (2012 - 2026)

Insmed's Return on Invested Capital history runs 12 years deep, the most recent figure standing at 0.48% for Q1 2026.

• On a quarterly basis, Return on Invested Capital fell 45.0% year-over-year to 0.48% in Q1 2026; TTM through Mar 2026 was 0.48%, a 45.0% decrease from a year earlier, with the FY2025 full-year figure at 0.49%, down 18.0% from the prior year.
• Return on Invested Capital climbed to 0.48% in Q1 2026 per INSM's latest filing, from 0.49% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.02% in Q3 2024 and bottomed at 0.49% in Q4 2025.
• The 5-year median for Return on Invested Capital is 0.22% (2023), against an average of 0.2%.
• Across the five-year window, Return on Invested Capital increased 22 bps in 2024 and tumbled 47 bps in 2025, its largest moves.
• Year by year, Return on Invested Capital stood at 0.2% in 2022, then declined by 17 bps to 0.24% in 2023, then jumped by 92 bps to 0.02% in 2024, then sank by 2550 bps to 0.49% in 2025, then grew by 2 bps to 0.48% in 2026.
• Per Business Quant, the three latest INSM Return on Invested Capital figures stand at 0.48% (Q1 2026), 0.49% (Q4 2025), and 0.43% (Q3 2025).